Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pinpin Sui

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Leukemia|January 26, 2026
Phf6 truncating mutation drives leukemogenesis via disrupted epigenetic regulation in miceYing Guo, Pinpin Sui, Hui Yang, et al.
National Science Review|October 25, 2021
Ecological principle meets cancer treatment: treating children with acute myeloid leukemia with low-dose chemotherapyYixin Hu, Aili Chen, Xinchang Zheng, et al.
Nature Communications|October 17, 2018
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancersYi Ding, Chang Gong, De Huang, et al.
The Journal of Clinical Investigation|November 2, 2023
Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical modelsGuo Ge, Peng Zhang, Pinpin Sui, et al.
EMBO Reports|August 31, 2023
Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clippingHui Yang, Pinpin Sui, Ying Guo, et al.
Cell Stem Cell|February 15, 2025
PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1Juyeong Hong, Pinpin Sui, Ying Li, et al.
Blood|March 31, 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AMLZhe Wang, Anna Skwarska, Gowri Poigaialwar, et al.
Cell Research|November 18, 2017
Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemiaLiang Huang, Dan Liu, Na Wang, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Leukemia|January 26, 2026
Phf6 truncating mutation drives leukemogenesis via disrupted epigenetic regulation in miceYing Guo, Pinpin Sui, Hui Yang, et al.
National Science Review|October 25, 2021
Ecological principle meets cancer treatment: treating children with acute myeloid leukemia with low-dose chemotherapyYixin Hu, Aili Chen, Xinchang Zheng, et al.
Nature Communications|October 17, 2018
Synthetic lethality between HER2 and transaldolase in intrinsically resistant HER2-positive breast cancersYi Ding, Chang Gong, De Huang, et al.
The Journal of Clinical Investigation|November 2, 2023
Targeting lysine demethylase 6B ameliorates ASXL1 truncation-mediated myeloid malignancies in preclinical modelsGuo Ge, Peng Zhang, Pinpin Sui, et al.
EMBO Reports|August 31, 2023
Loss of BRD4 induces cell senescence in HSC/HPCs by deregulating histone H3 clippingHui Yang, Pinpin Sui, Ying Guo, et al.
Cell Stem Cell|February 15, 2025
PSPC1 exerts an oncogenic role in AML by regulating a leukemic transcription program in cooperation with PU.1Juyeong Hong, Pinpin Sui, Ying Li, et al.
Blood|March 31, 2025
Efficacy of a Novel BCL-xL Degrader, DT2216, in Preclinical Models of JAK2-mutated Post-MPN AMLZhe Wang, Anna Skwarska, Gowri Poigaialwar, et al.
Cell Research|November 18, 2017
Integrated genomic analysis identifies deregulated JAK/STAT-MYC-biosynthesis axis in aggressive NK-cell leukemiaLiang Huang, Dan Liu, Na Wang, et al.
Pageof 2